Home > Insider Trading > Filing (0001415889-23-003930)

Filing Details

Accession Number:: 0001415889-23-003930
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-02 20:18:26
Reporting Period:: 2023-02-28

Accepted Time:: 2023-03-02 20:18:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
856982	Merit Medical Systems Inc	MMSI	Surgical & Medical Instruments & Apparatus (3841)	870447695

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901534	P Fred Lampropoulos	1600 West Merit Parkway South Jordan UT 84095	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, No Par Value	Acquisiton	2023-02-28	27,159	$0.00	1,025,582	No	4	A	Direct
Common Stock, No Par Value	Disposition	2023-02-28	12,030	$70.58	1,013,552	No	4	F	Direct
Common Stock, No Par Value	Disposition	2023-03-01	1,483	$70.17	1,012,069	No	4	S	Direct
Common Stock, No Par Value	Disposition	2023-03-02	19,176	$69.86	992,893	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified stock options (right to buy)	Acquisiton	2023-02-28	54,302	$0.00	54,302	$70.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
54,302	2024-02-28	2030-02-28	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, No Par Value	96,841	Indirect	By 401(k) Plan
Common Stock, No Par Value	90	Indirect	By spouse as custodian for child
Common Stock, No Par Value	6,888	Indirect	By spouse

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-qualified stock options (right to buy)	$28.20	2018-04-14	2024-04-14	200,000	200,000	Direct
Common Stock	Non-qualified stock options (right to buy)	$28.20	2018-04-14	2024-04-14	6,000	6,000	Indirect
Common Stock	Non-qualified stock options (right to buy)	$44.80	2019-03-02	2025-03-02	38,002	38,002	Direct
Common Stock	Non-qualified stock options (right to buy)	$44.80	2019-03-02	2025-03-02	4,000	4,000	Indirect
Common Stock	Non-qualified stock options (right to buy)	$55.73	2020-03-01	2026-03-01	159,151	159,151	Direct
Common Stock	Non-qualified stock options (right to buy)	$55.73	2020-03-01	2026-03-01	2,000	2,000	Indirect
Common Stock	Non-qualified stock options (right to buy)	$37.71	2021-02-26	2027-02-26	100,334	100,334	Direct
Common Stock	Non-qualified stock options (right to buy)	$56.25	2022-03-19	2028-03-19	58,083	58,083	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-04-14	200,000	200,000	Direct
2024-04-14	6,000	6,000	Indirect
2025-03-02	38,002	38,002	Direct
2025-03-02	4,000	4,000	Indirect
2026-03-01	159,151	159,151	Direct
2026-03-01	2,000	2,000	Indirect
2027-02-26	100,334	100,334	Direct
2028-03-19	58,083	58,083	Direct

Footnotes

These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.26.2020 and 03.19.2021.
These shares were not sold in an open-market transaction.
The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.44 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.6 to $70.1 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents plan holdings as of 01/31/2023.
Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
Becomes exercisable in equal annual installments of 25% commencing 02/28/2024.
Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.
Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.
Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.